Subscribe to our newsletter
Kevin Doxzen

Kevin Doxzen

I received my PhD from the lab of Jennifer Doudna, pioneer in CRISPR genome editing. I am now a Hoffmann Fellow joint between Arizona State University and the World Economic Forum. My focus is on policy and governance challenges in precision medicine and healthcare.

Follow Kevin:

From This Author

Gene Therapies Are Almost Here, But Healthcare Isn’t Ready for Sky-High Prices

-
Zolgensma—which treats spinal muscular atrophy, a rare genetic disease that damages nerve cells, leading to muscle decay—is currently the most expensive drug in the world. A one-time treatment of the life-saving drug for a...
Read more

Singularity University, Singularity Hub, Singularity Summit, SU Labs, Singularity Labs, Exponential Medicine, Exponential Finance and all associated logos and design elements are trademarks and/or service marks of Singularity Education Group.

© 2021 Singularity Education Group. All Rights Reserved.

Singularity University is not a degree granting institution.